Buclizine dihydrochloride

Modify Date: 2024-01-08 10:31:13

Buclizine dihydrochloride Structure
Buclizine dihydrochloride structure
Common Name Buclizine dihydrochloride
CAS Number 129-74-8 Molecular Weight 505.950
Density N/A Boiling Point 520.1ºC at 760 mmHg
Molecular Formula C28H35Cl3N2 Melting Point 230-240ºC
MSDS N/A Flash Point 268.3ºC

 Use of Buclizine dihydrochloride


Buclizine dihydrochloride is an orally active antihistamine antiallergic compound. Buclizine dihydrochloride is a potent teratogen in the rat[1][2][3].

 Names

Name anileridine dihydrochloride
Synonym More Synonyms

 Buclizine dihydrochloride Biological Activity

Description Buclizine dihydrochloride is an orally active antihistamine antiallergic compound. Buclizine dihydrochloride is a potent teratogen in the rat[1][2][3].
Related Catalog
In Vitro Buclizine (0-100 μM, 72 h) inhibited cancer cell growth by binding to TCTP and induction of cell differentiation[3]. Cell Proliferation Assay[3]. Cell Line: MCF-7 cells[3]. Concentration: 0-100 μM. Incubation Time: 72 h. Result: The IC50 was 19.18 ± 5.32 μM.
In Vivo Buclizine dihydrochloride (≥40 mg/kg) exhibits teratogenic effect[1]. Buclizine dihydrochloride exhibits the t1/2 of ~10 h via oral administration[2]. Animal Model: Eighty-seven mature female rats weighing 240±20 grams[1]. Dosage: 30-200 mg/kg. Administration: From days 10 to 15. Result: Exhibits teratogenic effect dose-dependently when ≥40 mg/kg.
References

[1]. C T King, et al. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol. 1966 May 1;95(1):109-11.

[2]. Nawab Sher, et al. Simultaneous determination of antihistamine anti-allergic drugs, cetirizine, domperidone, chlorphenamine maleate, loratadine, meclizine and buclizine in pharmaceutical formulations, human serum and pharmacokinetics application. Analytical methods • March 2014.

[3]. Ean-Jeong Seo, et al. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy. Oncotarget . 2016 Mar 29;7(13):16818-39.

 Chemical & Physical Properties

Boiling Point 520.1ºC at 760 mmHg
Melting Point 230-240ºC
Molecular Formula C28H35Cl3N2
Molecular Weight 505.950
Flash Point 268.3ºC
Exact Mass 504.186584
PSA 6.48000
LogP 8.02450
Vapour Pressure 6.44E-11mmHg at 25°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TL0280000
CHEMICAL NAME :
Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl )-, dihydrochloride
CAS REGISTRY NUMBER :
129-74-8
LAST UPDATED :
199701
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C28-H33-Cl-N2.2Cl-H
MOLECULAR WEIGHT :
506.00
WISWESSER LINE NOTATION :
T6N DNTJ AYR&R DG& D1R DX1&1&1 &GH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2100 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Lungs, Thorax, or Respiration - other changes
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 43,653,1954
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
430 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Lungs, Thorax, or Respiration - other changes
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 43,653,1954 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
360 mg/kg
SEX/DURATION :
female 10-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 95,109,1966

 Safety Information

Hazard Codes Xi

 Synonyms

1-(p-Chlorobenzhydryl)-4-(p-tert-butylbenzyl)piperazine dihydrochloride
Posdel
1-(p-Chlorobenzhydryl)-4-(p-tert-butylbenzyl)diethylenediamine dihydrochloride
1-(4-tert-Butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine dihydrochloride
MFCD00242700
Buclina
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride
1-(p-tert-Butylbenzyl)-4-(p-chloro-a-phenylbenzyl)piperazine Dihydrochloride
1-[(4-Chlorophenyl)(phenyl)methyl]-4-[4-(2-methyl-2-propanyl)benzyl]piperazine dihydrochloride
Postafen
BUCLIZINE, DIHYDROCHLORIDE
buclizine hydrochloride
Piperazine, 1- (p-tert-butylbenzyl)-4-(p-chloro-α-phenylbenzyl)-, dihydrochloride
buclizine dihydrochloride
Longifene
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, hydrochloride (1:2)
1-(p-tert-Butylbenzyl)-4-(p-chloro-α-phenylbenzyl)piperazine dihydrochloride
Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-α-phenylbenzyl)-, dihydrochloride
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Buclizine dihydrochloride suppliers


Price: ¥500/100 mg

Reference only. check more Buclizine dihydrochloride price